| Name | Otterbein Sunset House |
|---|---|
| Location | 4020 Indian Rd, Toledo, Ohio |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 20 |
| Occupancy Rate | 89% |
| Medicare ID (CCN) | 366148 |
| Legal Business Name | Sunset Retirement Communities Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1437125358 |
| Organization Name | SUNSET RETIREMENT COMMUNITIES, INC |
| Doing Business As | SUNSET HOUSE |
| Address | 4020 Indian Rd, Toledo, OH 43606 |
| Phone Number | 419-536-4645 |
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers' knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
On February 29, which is Rare Disease Day, Steven Libutti, MD, Vice Chairman of Surgery and Director of the Montefiore Einstein Center for Cancer Care will host a Twitter chat about the signs and symptoms, diagnosis and treatment of neuroendocrine tumors, or NETs, a rare form of cancer.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
NeoPharm, Inc., a publicly traded biopharmaceutical company dedicated to the research, development and commercialization of new and innovative therapeutic applications of drugs for various forms of cancer and other diseases, today announced its second quarter 2010 financial results.
A new program led by The University of Kansas Cancer Center seeks to improve community oncology providers' knowledge of genetic testing in breast cancer patients, as well as provide tools to allow genetic counseling and testing to be incorporated in their clinical practice.
Hepatologists - physicians who specialize in liver disease - say they experience workplace discrimination, especially if they are women or BIPOC (an acronym that stands for Black, Indigenous or People of Color).
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
On February 29, which is Rare Disease Day, Steven Libutti, MD, Vice Chairman of Surgery and Director of the Montefiore Einstein Center for Cancer Care will host a Twitter chat about the signs and symptoms, diagnosis and treatment of neuroendocrine tumors, or NETs, a rare form of cancer.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $650 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.87 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 10.87 | 5.51 |